BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38202217)

  • 1. Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years.
    Sticchi A; Tatali C; Ferraro M; Khokhar AA; Scoccia A; Cereda A; Toselli M; Gallo F; Laricchia A; Mangieri A; Grigioni F; Ussia GP; Giannini F; Colombo A
    J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cone Flare Crush Modified-T (CFCT) stenting technique for coronary artery bifurcation lesions.
    Peverill WT; Incani A; Worthley SG; Singbal Y; Garrahy PJ; McCann AB; Cox SV; Moore PT; Lim RYY; Fetahovic T; Connors GW; Hall C; Sieg C; Camuglia AC
    Int J Cardiol Heart Vasc; 2020 Oct; 30():100643. PubMed ID: 33015315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).
    Ohya M; Kadota K; Toyofuku M; Morimoto T; Higami H; Fuku Y; Yamaji K; Muranishi H; Yamaji Y; Nishida K; Furukawa D; Tada T; Ko E; Ando K; Sakamoto H; Tamura T; Kawai K; Kimura T;
    Am J Cardiol; 2017 Feb; 119(3):355-364. PubMed ID: 27887688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 5-year results of the TARGET Ⅱ trial].
    Xu LJ; Gao Z; Song Y; Wang HH; Xu JJ; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Yuan JQ; Qiao SB; Yang YJ; Xu B; Gao RL;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jul; 46(7):523-528. PubMed ID: 30032542
    [No Abstract]   [Full Text] [Related]  

  • 8. First generation versus second generation drug-eluting stents for the treatment of bifurcations: 5-year follow-up of the LEADERS all-comers randomized trial.
    Grundeken MJ; Wykrzykowska JJ; Ishibashi Y; Garg S; de Vries T; Garcia-Garcia HM; Onuma Y; de Winter RJ; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Meier B; Jüni P; Yazdani A; Copt S; Windecker S; Serruys PW
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):E248-60. PubMed ID: 26649651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of bivalirudin and paclitaxel-eluting stents on outcomes in patients undergoing primary percutaneous coronary intervention of the left anterior descending artery.
    Wöhrle J; Brodie B; Witzenbichler B; Dudek D; Kornowski R; Metzger C; Grines C; McAndrew TC; Parise H; Sergie Z; Mehran R; Stone GW
    Am J Cardiol; 2013 Sep; 112(6):753-60. PubMed ID: 23746479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Thin-Strut Stents in Non-Left Main Bifurcation Coronary Lesions: A RAIN Subanalysis.
    De Filippo O; D'Ascenzo F; Angelini F; Franchin L; Cerrato E; Pennacchi M; Nuñez-Gil I; Wojakowski W; Imori Y; Trabattoni D; Huczek Z; Venuti G; Muscoli S; Iannaccone M; Montabone A; Marengo G; Rognoni A; Parma R; Figini F; Mitomo S; Boccuzzi G; Mattesini A; Quadri G; Wańha W; Smolka G; Rolfo C; Cortese B; Ryan N; Capodanno D; Chieffo A; di Mario C; Varbella F; Romeo F; Sheiban I; Escaned J; Helft G; De Ferrari GM
    J Invasive Cardiol; 2021 Nov; 33(11):E890-E899. PubMed ID: 34735352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT Trial.
    Roguin A; Camenzind E; Kerner A; Beyar R; Boersma E; Mauri L; Steg PG; Wijns W
    JACC Cardiovasc Interv; 2017 Mar; 10(6):548-556. PubMed ID: 28335893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries.
    Ashby DT; Dangas G; Mehran R; Lansky AJ; Narasimaiah R; Iakovou I; Polena S; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Am J Cardiol; 2002 May; 89(10):1162-6. PubMed ID: 12008168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus-eluting stent implantation for ostial left anterior descending coronary artery lesions: three-year outcome from the j-Cypher Registry.
    Kishi K; Kimura T; Morimoto T; Namura M; Muramatsu T; Nishikawa H; Hiasa Y; Isshiki T; Nobuyoshi M; Mitsudo K;
    Circ Cardiovasc Interv; 2011 Aug; 4(4):362-70. PubMed ID: 21712527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trial.
    Farooq V; Serruys PW; Zhang Y; Mack M; Ståhle E; Holmes DR; Feldman T; Morice MC; Colombo A; Bourantas CV; de Vries T; Morel MA; Dawkins KD; Kappetein AP; Mohr FW
    J Am Coll Cardiol; 2013 Dec; 62(25):2360-2369. PubMed ID: 24140677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system.
    Triantafyllis AS; Bennett J; Pagourelias E; McCutcheon K; Adriaenssens T; Sinnaeve PR; Desmet W; Dubois C
    Cardiol J; 2018; 25(4):470-478. PubMed ID: 29240962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Siddiqi TJ; Khan MS; Karimi Galougahi K; Shlofmitz E; Moses JW; Rao S; West NEJ; Wolff E; Hochler J; Chau K; Khalique O; Shlofmitz RA; Jeremias A; Ali ZA
    Catheter Cardiovasc Interv; 2022 Nov; 100 Suppl 1():S44-S56. PubMed ID: 36251325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
    Giacoppo D; Alvarez-Covarrubias HA; Koch T; Cassese S; Xhepa E; Kessler T; Wiebe J; Joner M; Hochholzer W; Laugwitz KL; Schunkert H; Kastrati A; Kufner S
    Eur Heart J; 2023 Apr; 44(15):1343-1357. PubMed ID: 36807512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.